Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
LIVN
LivaNova PLC
NASDAQGS
Medical Devices
United Kingdom
$81.25
▲
+0.59 (+0.73%)
CLOSED
—
OPEN
$81.92
HIGH
$82.28
LOW
$81.05
PREV CLOSE
$80.66
VOLUME
483.3K
0.75x avg
BID / ASK
58.04 / 104.44
spr 46.40
MARKET CAP
$4.46B
DAY RANGE
$81.05
$82.28
P/E (TTM)
24.04
Fwd 17.3
EPS (TTM)
3.38
DIV YIELD
0.00%
52W HIGH
$85.76
-5.3%
52W LOW
$48.82
+66.4%
BETA
0.88
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$81.25
+0.00
(+0.00%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
LIVN
$81.25
▲
+0.73%
Chart
Valuation
Financials
Peers
News
LIVN · K 線技術分析（即時、可互動）
basic
pro
快速分析（約半分鐘，最長 5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，通常約半分鐘，上游壅塞時最長 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
RISK-ON
251 BARS · +53.9% YOY
1-year price chart. Started at 52.79, currently 81.25, up 53.9 percent. Range 49.57 to 85.32 over 251 data points.
2025-10-30
$52.79 → $81.25 (+53.9%)
2026-10-29
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
RISK-OFF
DCF FV $68.53 · -15.7% VS SPOT
DCF Fair Value
$68.53
DCF vs Spot
-15.7%
Comps Fair Value
—
WACC Used
+9.1%
Terminal g
+2.5%
判定: sell
· DCF $68.53 (-15.7%) · method: DCF only
⚠ Cohort refused: no sector classification for LIVN, so its peer set cannot be validated and is not published.
FINANCIALS
多年財務（SEC XBRL）
RISK-ON
YOY REV +10.7% · 4 FY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$1.39B
-$242.5M
$254.3M
$173.3M
$2.61B
2024-12
$1.25B
$63.2M
$183.0M
$135.9M
$2.51B
2023-12
$1.15B
$17.5M
$74.9M
$39.9M
$2.43B
2022-12
$1.02B
-$86.2M
$69.9M
$43.4M
$2.29B
PEERS
同業與產業對照
CALM
8 PEERS · FINNHUB
SN.L
NIOX.L
EKF.L
CREO.L
IHC.L
EMVC.L
CLBX.L
SUN.L
NEWS
近期新聞（過去 14 天）
CALM
18 HEADLINES · LAST 14 DAYS
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates
Zacks · 2026-10-28
Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova’s VNS Therapy for Drug-Resistant Epilepsy
Business Wire · 2026-10-23
LivaNova to Present at UBS, Wolfe, Stifel, and Jefferies Healthcare Conferences in November
Business Wire · 2026-10-21
Stephen K. Brannan, MD, and John D. Young Appointed to Slate Medicines Board of Directors
Exec Edge · 2026-10-20
LivaNova (LIVN) Stock Looks Undervalued As Its 60% Three Year Run Continues
Simply Wall St. · 2026-10-09
LivaNova (LIVN) Narrative Keeps Fair Value In Focus As Shares Cool
Simply Wall St. · 2026-10-09
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
The Fly · 2026-10-07
Operating Leverage and Product Innovation Drive LivaNova’s(LIVN) Sustained Profit Outlook
Insider Monkey · 2026-09-24